|
Session 147
Poster Abstracts
HIV-Associated Nephropathy and other Nephratoxicity Disease
Monday, 1 - 4 pm
Poster Hall |
825
 |
HIV-1 Vpr Induces G2 Arrest and Apoptosis in Human Kidney Proximal Tubule Cells: Implications for HIV-associated Nephropathy Pathogenesis
Paul Rosenstiel*1, A Letourneau2, P Klotman1, and M Klotman1
1Mt Sinai Sch of Med, New York, NY, US and 2Inst Jacques Monod, Paris, France |
| 826 |
Factors Associated with Renal Dysfunction within an Urban Cohort in the Era of HAART
E Overton1, D Nurutdinova*1, J Freeman1,2, J Freeman1,2, D Finn1, W Seyfried1, and K Mondy1
1Washington Univ Sch of Med, St Louis, MO, US and 2Univ of Illinois at Chicago, Coll of Pharmacy, US |
827
|
The Association between Suppression of HIV-1 Replication and Glomerular Filtration Rates among Subjects on ACTG A5001 (The ALLRT)
Robert Kalayjian*1, N Fransceschini2, S Gupta3, L Szczech4, E Mupere5, M Smurzynski6, J Albert5, and the Adult AIDS Clinical Trials Group Longitudinal Linked Randomized Study (ALLRT)
1MetroHlth Med Ctr, Cleveland, OH, US; 2Univ of North Carolina at Chapel Hill, US; 3Indiana Univ Sch of Med, Indianapolis, US; 4Duke Univ, Durham, NC, US; 5Case Western Reserve Univ, Cleveland, OH, US; and 6Harvard Sch of Publ Hlth, Boston, MA, US |
| 828 |
Detection of Chronic Renal Failure among HIV Patients within the EuroSIDA Study
Amanda Mocroft*1, O Kirk2, J Gatell3, P Reiss4, P Gargalianos-Kakolyris5, K Zilmer6, M Beniowski7, J P Viard8, S Staszewski9, J Lundgren2, and The EuroSIDA Study Group
1Univ Coll London, Royal Free Hosp, UK; 2Copenhagen HIV Prgm, Hvidovre, Denmark; 3Hosp Clin of Barcelona, Spain; 4Univ of Amsterdam, The Netherlands; 5Gen Hosp of Athens, Greece; 6West-Tallinn Central Hosp, Estonia; 7Szpital Specjalistyczny, Chorzow, Poland; 8Hosp Necker-Enfants Malades, Paris, France; and 9JW Goethe Univ Hosp, Frankfurt, Germany |
829
|
End Stage Renal Disease Risk in HIV-infected African Americans: 12-fold Higher than Age- and Race-adjusted National Rate and Increasing in the HAART Era
Gregory Lucas*1, S Mehta1, P O'Driscoll1, M Atta1, G Kirk1, N Galai1,2, N Galai1,2, D Vlahov1,3, D Vlahov1,3, R Moore1, and Johns Hopkins HIV Cohort; ALIVE study
1Johns Hopkins Univ, Baltimore, MD, US; 2Univ of Haifa, Israel; and 3New York Academy of Med, NY, US |
| 830 |
Cystatin C in HIV Infection: A Marker of Pre-clinical Kidney Disease
Michelle Odden*1, R Scherzer1, L Szczech2, S Sidney3, P Bacchetti1,4, P Bacchetti1,4, C Grunfeld1,4, C Grunfeld1,4, M Shlipak1,4, and M Shlipak1,4
1San Francisco VAMC, CA, US; 2Duke Univ Med Ctr, Durham, NC, US; 3Kaiser Permanente, Oakland, CA, US; and 4Univ of California, San Francisco Sch of Med, US |
| 831 |
Amphotericin-B-associated Nephrotoxicity among HIV/AIDS Patients Treated for Cryptococcal Meningitis in a Resource-poor Setting
Francis Kiweewa*1, F Matovu1, S Kiwuwa1, H Mayanja-Kizza1, and E Kigonya2
1Makerere Univ Teaching Hosp, Kampala, Uganda and 2Mulago Natl Referral Hosp, Kampala Uganda |
|
